Dr Eslick is currently the Co-Director of The Whiteley-Martin Research Centre at The University of Sydney and the Professor of Cancer Epidemiology and Medical Statistics. Director of research in LHD.
His education consists of a Bachelor of Applied Science (Pathology), Graduate Diploma in Epidemiology, Master of Medical Science in Clinical Epidemiology, Master of Medical Statistics, Doctor of Philosophy (Medicine), and Doctor of Public Health.
He is a Fellow of the International Union for Cancer Control (UICC), and a Fellow of the American College of Epidemiology, and a Fellow of the Faculty of Public Health in the United Kingdom.
He has undertaken post-doctoral training at The University of Sydney, School of Public Health, where he conducted research on the relationship between gastrointestinal symptoms and obesity. In addition, he then went overseas for further post-doctoral training at The Harvard School of Public Health, Boston, where he undertook research on risk factors associated with developing oesophageal cancer.
He has extensive research experience in many areas of medicine including: oncology (cancer medicine), surgery, neurology, infectious diseases, cardiology, gastroenterology, sexual health, dermatology, critical care medicine, and others.
This quote highlights the importance of getting advice from an experienced epidemiologist well before you begin designing your research study. Undertaking superior quality research studies will ultimately provide the ‘truth’ and lead the way for future research in any area of medicine or health.
Our aim is to provide you with not only results, but also an understanding of those results and what it means for you and the impact this has on your research question. We provide independent confidential advice and analysis on all aspects of medical and health-based research.
Dr Eslick has published over 300 papers in peer-reviewed medical journals.
Dr Eslick is the Editor-in-Chief of the American Journal of Cancer Epidemiology and Prevention. He has also been an Associate Editor of the American Journal of Epidemiology, and is currently an Associate Editor-in-Chief of the World Journal of Gastroenterology, and an Associate Editor of the Journal of Alzheimer’s Disease. He is on the Editorial Boards of the European Journal of Surgical Oncology, Journal of Clinical Epidemiology, Alimentary Pharmacology and Therapeutics, Rare Cancers and Therapy, Rare Tumors, and the World Journal of Gastrointestinal Oncology.
He is also a Statistical Consultant for the medical journals: Circulation, Medical Journal of Australia, Journal of Clinical Oncology, and the Journal of Thoracic and Cardiovascular Surgery.
He was recently awarded the Sir Richard Stawell prize for a piece of research “on a medical subject of clinical significance, which is original, evidence-based and which is likely to advance knowledge, influence clinical practice and improve the health of Australians.” The prize for research into the evaluation of an acute surgical unit as a novel model of care for patients presenting with acute cholecystitis.